Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This locus represents a novel antisense RNA transcript overlapping the VSIG8 gene, identified in genomic annotation databases as ENSG00000272668 and LOC124904434. As a non-coding RNA, it may participate in post-transcriptional regulation of the VSIG8 gene, but its specific function remains uncharacterized. Natural antisense transcripts often modulate the expression of overlapping protein-coding genes, sometimes influencing gene silencing, chromatin state, or transcript stability[9][6]. There are currently no reports of direct involvement in disease, therapeutic targeting, or use as a biomarker. Most scientific and clinical research focuses on the protein-coding VSIG8 gene, which is an immune checkpoint molecule and a potential immunotherapy target, rather than on its antisense transcript[1][2][4][7].
None. No mechanisms of drug action are described for this non-coding transcript.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to VSIG8 (ENSG00000272668; LOC124904434).